Literature DB >> 33349795

A RARE CASE OF RAPIDLY ENLARGING MYELOLIPOMA IN SICKLE CELL DISEASE.

Paran Davari, Cortney Youens Lee, James Te-An Lee.   

Abstract

OBJECTIVE: Adrenal myelolipoma (AM) is a benign tumor composed of mature fat cells and hemopoietic elements. Most AMs are incidental findings on imaging and clinically asymptomatic. The purpose of this case report is to describe a rare case of AM and explore its clinical manifestations, imaging features, and treatment.
METHODS: In this study, we report a case of a rapidly growing right AM in a patient with uncontrolled hemoglobin sickle cell disease. A 38-year-old male presented to our institution's endocrine surgery clinic for evaluation of an enlarging right adrenal mass. This mass was incidentally found during an abdominal ultrasound performed for transaminitis and thrombocytopenia. Patient was asymptomatic without any abdominal discomfort, back pain, nausea, or vomiting.
RESULTS: Patient was lost to follow up until 2018. Follow-up computed tomography scan in 2018 showed the right adrenal mass measuring 12.3 cm in greatest dimension with significant macroscopic fat. Given the imaging features, AM was the presumed diagnosis. However, with a medical history of uncontrolled sickle cell disease, extra-medullary hematopoiesis and rapidly growing liposarcoma could not be ruled out. Surgical excision was performed due to size and significant tumor growth. Diagnosis was confirmed with histopathology and revealed myelolipoma.
CONCLUSION: Image characteristics can be helpful in diagnosis of AM; however, the appearance of this lesion on computed tomography can be similar to other adrenal gland pathologies such as liposarcoma and mass-forming extramedullary hematopoiesis. Percutaneous needle biopsy may be indicated if the diagnosis remains unclear.
Copyright © 2020 AACE.

Entities:  

Year:  2020        PMID: 33349795      PMCID: PMC7282148          DOI: 10.4158/ACCR-2019-0402

Source DB:  PubMed          Journal:  AACE Clin Case Rep        ISSN: 2376-0605


  19 in total

1.  Giant myelolipoma in a patient with thalassemia intermedia.

Authors:  W Y Au; P C Tam; S K Ma; K Y Lam
Journal:  Am J Hematol       Date:  2000-11       Impact factor: 10.047

2.  Adrenal myelolipomas show nonrandom X-chromosome inactivation in hematopoietic elements and fat: support for a clonal origin of myelolipomas.

Authors:  Elena Bishop; John N Eble; Liang Cheng; Mingsheng Wang; Donald R Chase; Attilio Orazi; Dennis P O'Malley
Journal:  Am J Surg Pathol       Date:  2006-07       Impact factor: 6.394

3.  Extraadrenal myelolipoma: MR imaging findings.

Authors:  B F Kammen; D E Elder; D L Fraker; E S Siegelman
Journal:  AJR Am J Roentgenol       Date:  1998-09       Impact factor: 3.959

4.  Extra-adrenal myelolipoma and extramedullary hematopoiesis: Imaging features of two similar benign fat-containing presacral masses that may mimic liposarcoma.

Authors:  Laurel A Littrell; Jodi M Carter; Stephen M Broski; Doris E Wenger
Journal:  Eur J Radiol       Date:  2017-05-29       Impact factor: 3.528

5.  Extramedullary hematopoiesis in the adrenal: Case report and review of literature.

Authors:  John Samuel Banerji; Ramani Manoj Kumar; Antony Devasia
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

6.  Ten years of laparoscopic adrenalectomy: lesson learned from 104 procedures.

Authors:  Giovanni Ramacciato; Mercantini Paolo; Amodio Pietromaria; Buniva Paolo; D'Angelo Francesco; Petrocca Sergio; Stigliano Antonio; Toscano Vincenzo; Piccoli Micaela; Melotti Gianluigi
Journal:  Am Surg       Date:  2005-04       Impact factor: 0.688

7.  Adrenal myelolipoma: CT and ultrasound findings.

Authors:  C W Vick; R K Zeman; E Mannes; J J Cronan; J W Walsh
Journal:  Urol Radiol       Date:  1984

8.  Presacral extramedullary hematopoiesis in thalassemia intermedia.

Authors:  I A Sproat; J Dobranowski; V Chen; M Ali; D Woods
Journal:  Can Assoc Radiol J       Date:  1991-08       Impact factor: 2.248

9.  Giant adrenal myelolipoma with minimal fat content in a patient with homozygous beta-thalassemia: appearance on MRI.

Authors:  Nikolaos L Kelekis; Efthymia Alexopoulou; Elias N Brountzos; Vasilis Ladis; Angeliki Boussiotou; Dimitrios A Kelekis
Journal:  J Magn Reson Imaging       Date:  2003-11       Impact factor: 4.813

10.  Adrenal extramedullary hematopoietic tumor in a patient with beta-thalassemia.

Authors:  C K Chuang; S H Chu; J T Fang; J H Wu
Journal:  J Formos Med Assoc       Date:  1998-06       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.